Tao Zhang
Career
- Mr. Zhang has served the Department of Sports Medicine and the ICMRS Sports Medicine Research Center at Xiangya Hospital, Central South University, Changsha, from 2014 through 2026.
- His 46-record research class is almost entirely co-authored with Lu Hongbin on rotator cuff, tendon-bone healing, LIPUS, and scaffolds, with his remaining records carrying team coauthors.
- ORCID identifiers appear under his own author lines on team records co-authored with Lu Hongbin.
Research Work
- Mr. Zhang's research spans rotator cuff, tendon-bone healing, LIPUS, and scaffolds.
- ORCID identifiers appear under his author lines on team records; the first carries 2 works matching team titles (SIRT3 tendon degeneration, 2026; single-cell RNA sequencing enthesis, 2023).
- He is co-author of Study 13, a dose-response study in 120 mature New Zealand rabbits with standard partial patellectomies in which twice-daily low-intensity pulsed ultrasound stimulation produced more new bone formation and mineralization, a better histological interface, and significantly improved biomechanical properties than once-daily treatment or control.
Role in Study 13
Co-author of Study 13. See Study 13: Low-Intensity Pulsed Ultrasound Stimulation for Tendon-Bone Healing (American Journal of Physical Medicine & Rehabilitation, 2018; PMID 29016398).
Relationship statement: King Brand utilized the individual's work in the development of our products and treatments. The study and all the professional's work was independent of King Brand - they did not work for us, nor were they compensated by us - it is truly independent. King Brand has relied on the results of this study, this individual's work, and the work and studies of others in the development of our medical solutions.
Sources
ORCID identifier 0000-0002-6746-8834 · ORCID identifier 0000-0002-6797-8332 · ORCID-tagged records (PMIDs 42710873, 37698466, 36203341) · E-mail anchor record (PMID 35232904) · PubMed author class (Zhang Tao, Xiangya) · Study 13 on PubMed (PMID 29016398)
Profile verified as of 2026-09-20; annual re-verification scheduled.